Filing Details

Accession Number:
0000096943-21-000078
Form Type:
4
Zero Holdings:
No
Publication Time:
2021-06-11 18:08:39
Reporting Period:
2021-06-10
Accepted Time:
2021-06-11 18:08:39
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
96943 Teleflex Inc TFX Surgical & Medical Instruments & Apparatus (3841) 231147939
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1627036 P Cameron Hicks C/O 550 E. Swedesford Road
Suite 400
Wayne PA 19087
Corp. Vp & Chief Hr Officer No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2021-06-10 1,676 $101.12 10,280 No 4 M Direct
Common Stock Acquisiton 2021-06-10 1,800 $121.00 12,080 No 4 M Direct
Common Stock Disposition 2021-06-10 1,671 $395.05 10,409 No 4 S Direct
Common Stock Disposition 2021-06-10 1,205 $396.30 9,204 No 4 S Direct
Common Stock Disposition 2021-06-10 600 $397.21 8,604 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 M Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Option / (Right to Buy) Disposition 2021-06-10 1,676 $101.12 1,676 $101.12
Common Stock Stock Option / (Right to Buy) Disposition 2021-06-10 1,800 $121.00 1,800 $121.00
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
0 2024-02-26 No 4 M Direct
6,601 2025-02-25 No 4 M Direct
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 36 Indirect By 401(k) Trustee
Footnotes
  1. Transaction effected pursuant to a Rule 10b5-1 trading plan established by the reporting person on December 1, 2020.
  2. This transaction was executed in multiple trades at prices ranging from $394.37 to $395.34. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide, upon request, to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
  3. This transaction was executed in multiple trades at prices ranging from $395.72 to $396.71. The price reported reflects the weighted average sale price. The reporting person hereby undertakes to provide, upon request, to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
  4. This transaction was executed in multiple trades at prices ranging from $396.83 to $397.52. The price reported reflects the weighted average sale price. The reporting person hereby undertakes to provide, upon request, to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
  5. Exercisable for one-third of the shares on each of 2/26/2015, 2/26/2016 and 2/26/2017.
  6. Exercisable for one-third of the shares on each of 2/25/2016, 2/25/2017 and 2/25/2018.